Publication related to RSI or an RSI staff member

Neonatal mortality and morbidity in vertex-vertex second twins according to mode of delivery and birth weight.

OBJECTIVE: To assess the risk of neonatal mortality and morbidity in vertex-vertex second twins according to mode of delivery and birth weight. STUDY DESIGN: Data from a historical cohort study based on a twin registry in the US (1995-1997) were used. Multivariate logistic regression was used to control for maternal age, race, marital status, cigarette smoking during pregnancy, parity, medical complications, gestational age, and other confounders. RESULTS: A total of 86 041 vertex-vertex second twins were classified into two groups: second twins delivered by cesarean section after cesarean delivery of first twin (C-C) (43.0%), second twins whose co-twins delivered vaginally (V-X) (57.0%). In infants of birth weight>or=2500 g group, the risks of noncongenital anomaly-related death (adjusted odds ratio (aOR): 4.64, 95% confidence interval (95% CI): 1.90, 13.92), low Apgar score (aOR: 2.39, 95% CI: 1.43, 4.14), and ventilation use (aOR: 1.31, 95% CI: 1.18, 1.47) were higher in the V-X group compared with the C-C group. No asphyxia-related neonatal deaths occurred in C-C group, whereas the incidence of this death was 0.04% in the V-X group. CONCLUSION: The risks of neonatal mortality and morbidity are increased in vertex-vertex second twins with birth weight>or=2500 g whose co-twins delivered vaginally compared with second twins delivered by cesarean section after cesarean delivery of first twin.

Authors

  • Yang, Q, Yang Q, OMNI Research Group, Department of Obstetrics and Gynecology, Faculty of Medicine, University of Ottawa, and Ottawa Health Research Institute, Ottawa, Canada. qyang@ohri.ca

  • Wen, S W, Wen SW,

  • Chen, Y, Chen Y,

  • Krewski, D, Krewski D,

  • Fung Kee Fung, K, Fung Kee Fung K,

  • Walker, M, Walker M,

YEAR OF PUBLICATION: 2006
SOURCE: J Perinatol. 2006 Jan 1;26(1):3-10. doi: 10.1038/sj.jp.7211408.
JOURNAL TITLE ABBREVIATION: J Perinatol
JOURNAL TITLE: Journal of perinatology : official journal of the California Perinatal Association
ISSN: 0743-8346 (Print) 0743-8346 (Linking)
VOLUME: 26
ISSUE: 1
PAGES: 3-10
PLACE OF PUBLICATION: United States
ABSTRACT:
OBJECTIVE: To assess the risk of neonatal mortality and morbidity in vertex-vertex second twins according to mode of delivery and birth weight. STUDY DESIGN: Data from a historical cohort study based on a twin registry in the US (1995-1997) were used. Multivariate logistic regression was used to control for maternal age, race, marital status, cigarette smoking during pregnancy, parity, medical complications, gestational age, and other confounders. RESULTS: A total of 86 041 vertex-vertex second twins were classified into two groups: second twins delivered by cesarean section after cesarean delivery of first twin (C-C) (43.0%), second twins whose co-twins delivered vaginally (V-X) (57.0%). In infants of birth weight>or=2500 g group, the risks of noncongenital anomaly-related death (adjusted odds ratio (aOR): 4.64, 95% confidence interval (95% CI): 1.90, 13.92), low Apgar score (aOR: 2.39, 95% CI: 1.43, 4.14), and ventilation use (aOR: 1.31, 95% CI: 1.18, 1.47) were higher in the V-X group compared with the C-C group. No asphyxia-related neonatal deaths occurred in C-C group, whereas the incidence of this death was 0.04% in the V-X group. CONCLUSION: The risks of neonatal mortality and morbidity are increased in vertex-vertex second twins with birth weight>or=2500 g whose co-twins delivered vaginally compared with second twins delivered by cesarean section after cesarean delivery of first twin.
LANGUAGE: eng
DATE OF PUBLICATION: 2006 Jan 1
DATE COMPLETED: 20060504
DATE REVISED: 20211203
MESH DATE: 2006/05/05 09:00
EDAT: 2005/11/25 09:00
STATUS: MEDLINE
PUBLICATION STATUS: ppublish
COMMENT IN:
OWNER: NLM

Related RSI Experts

Daniel Krewski

Chief Risk Scientist

Dr. Daniel Krewski is Chief Risk Scientist and co-founder of Risk Sciences International (RSI), a firm established in 2006 to bring evidence-based, multidisciplinary expertise to the challenge of understanding, managing, and communicating risk. As RSI’s inaugural CEO and long-time scientific...
Read More about Daniel Krewski